The rising influence of several major medication companies is raising serious concerns worldwide. This trend towards domination regularly leads to increased medication costs, restricted innovation, and difficulties in obtaining vital therapies for individuals throughout the planet. Experts believ

India's pharmaceutical landscape presents a complex picture, largely shaped by the substantial influence of a few leading players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny